Treatment of nail psoriasis with 8% clobetasol nail lacquer: positive experience in 10 patients

Authors: Sánchez Regaña, M; Martín Ezquerra, G1; Umbert Millet, Pablo1; Llambí Mateos, F2

Source: Journal of the European Academy of Dermatology & Venereology, Volume 19, Number 5, September 2005 , pp. 573-577(5)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Background

Treatment of nail psoriasis is difficult. Several topical therapies have been employed with poor results because drug penetration is limited in this localization. Recently, a new formulation containing 8% clobetasol-17-propionate in a colourless nail lacquer vehicle has shown good results in the control of nail psoriasis. Objective

To determine the efficacy and safety of 8% clobetasol-17-propionate in a lacquer vehicle in nail psoriasis. Methods

Ten patients with both nail bed and matrix psoriasis were included in the study. They were treated with a colourless nail lacquer containing 8% clobetasol-17-propionate that was applied once daily for 21 days and then twice weekly for 9 months. Results

Within 4 weeks of therapy there was a reduction of all the nail alterations, including nail pain. Therapeutic response was directly related to the length of therapy. The nail parameters that responded best to therapy were onycholysis, pitting and salmon patches. Subungual hyperkeratosis and splinter haemorrhages on the other hand had moderate and poor improvement, respectively. The treatment was well tolerated in all of the patients and there were no local (i.e. atrophy and sobreinfection) or systemic secondary effects. Conclusions

The formulation containing 8% clobetasol-17-propionate is a safe, effective and cosmetically highly acceptable treatment for nail bed and matrix psoriasis.

Keywords: clobetasol; nail lacquer; nail; psoriasis

Document Type: Research article

DOI: 10.1111/j.1468-3083.2005.01253.x

Affiliations: 1: Psoriasis Center, Department of Dermatology, Hospital Universitari Sagrat Cor, Teaching Unit of University of Barcelona, Barcelona, 2: Pharmacy of the Community, Barcelona, Spain.

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$54.87 plus tax

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A